Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Marvell (MRVL) gets a Buy: undervalued AI data center play with custom networking growth, plus key risks (China, capex, ...

Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...

EADaily, . After the high-profile political events, 2025 was supposed to be a calmer and somewhat transitional year for ...

Visa Inc. V, a global leader in payment processing, continues to deliver what long-term investors value most: consistency.

Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.

The 2025 US National Security Strategy shifts the United States decisively away from expansive regional engagement in the South Caucasus, instead favoring selective, interest-driven involvement.

Russia’s manipulation of history has evolved from symbolic memory politics into a deliberate instrument of state power aimed ...

As alcohol use among college students drops and cannabis use surges, campus leaders must adapt safety planning accordingly.

Is the inside of a vision model at all like a language model? Researchers argue that as the models grow more powerful, they ...